Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone. Issue 6 (19th March 2021)

Record Type:
Journal Article
Title:
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone. Issue 6 (19th March 2021)
Main Title:
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
Authors:
Korde, Neha
Mastey, Donna
Tavitian, Elizabet
Mailankody, Sham
Lesokhin, Alexander
Hassoun, Hani
Smith, Eric L.
Lendvai, Nikoletta
Hultcrantz, Malin
Shah, Urvi
Tan, Carlyn
Lu, Sydney
Diamond, Benjamin
Salcedo, Meghan
Werner, Kelly
Chung, David J.
Scordo, Michael
Shah, Gunjan L.
Lahoud, Oscar
Landau, Heather
Arcila, Maria
Ho, Caleb
Roshal, Mikhail
Dogan, Ahmet
Derkach, Andriy
Devlin, Sean M.
Giralt, Sergio A.
Landgren, Ola
Abstract:
Is Part Of:
American journal of hematology. Volume 96:Issue 6(2021)
Journal:
American journal of hematology
Issue:
Volume 96:Issue 6(2021)
Issue Display:
Volume 96, Issue 6 (2021)
Year:
2021
Volume:
96
Issue:
6
Issue Sort Value:
2021-0096-0006-0000
Page Start:
E193
Page End:
E196
Publication Date:
2021-03-19
Subjects:
Hematology -- Periodicals
616.15
Journal URLs:
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1002/ajh.26150 ↗
Languages:
English
ISSNs:
0361-8609
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
24642.xml